BIGG

SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline

Sheyu, Li; Per, Vandvik; Lyubov, Lytvyn; Guyatt, Gordon; Palmer, Suetonia.

BMJ (Online); 373 (), 2021

Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...

Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico, Receptor del Péptido 1 Similar al Glucagón/uso terapéutico, Diabetes Mellitus Tipo 2/tratamiento farmacológico, Control Glucémico/normas, Glucemia/efectos de los fármacos

Texto completo

VA/DoD clinical practice guideline for the management of type 2 diabetes mellitus in primary care

U.S. Department of Veterans Affairs.

DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...

Diabetes Mellitus Tipo 2, Diabetes Mellitus, Biomarcadores/sangre, Glucemia/metabolismo, Angiopatías Diabéticas/prevención & control, Fructosamina/sangre, Hemoglobina Glucada/metabolismo, Hipoglucemiantes/uso terapéutico, Esperanza de Vida, Prioridad del Paciente, Atención Dirigida al Paciente, Hemoglobina Glucada, Hipoglucemiantes

Texto completo (enlace principal) Texto completo (enlace alternativo)

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

Peters, AL; Ahmann, AJ; Battelino, T; Evert, A; Hirsch, IB; Murad, MH; Winter, WE; Wolpert, H.

J. clin. endocrinol. metab; 101 (11), 2016

"OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...

Texto completo